PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
International Journal of Stroke10.1177/17474930156208042016114485-491Protocol for the comparison of triflusal and clopidogrel in secondary prevention of stroke based on cytochrome P450 2C19 genotyping (MASETRO study): A multicenter, randomized, open-label, parallel-group trialSang Won Han, Yong-Jae Kim, Seong Hwan Ahn, Woo-Keun Seo, Sungwook Yu, Seung-Hun Oh, Youn Nam Kim, Kyung-Yul Lee, http://journals.sagepub.com/doi/pdf/10.1177/1747493015620804, http://journals.sagepub.com/doi/full-xml/10.1177/1747493015620804, http://journals.sagepub.com/doi/pdf/10.1177/1747493015620804
Journal of Stroke10.5853/jos.2017.012492017193356-364Effects of Triflusal and Clopidogrel on the Secondary Prevention of Stroke Based on Cytochrome P450 2C19 GenotypingSang Won Han, Yong-Jae Kim, Seong Hwan Ahn, Woo-Keun Seo, Sungwook Yu, Seung-Hun Oh, Hyo Suk Nam, Hye-Yeon Choi, Sung Sang Yoon, Seo Hyun Kim, Jong Yun Lee, Jun Hong Lee, Yang-Ha Hwang, Kee Ook Lee, Yo Han Jung, Jun Lee, Sung-Il Sohn, Youn Nam Kim, Kyung-A Lee, Cheryl D Bushnell, Kyung-Yul Leehttp://j-stroke.org/upload/pdf/jos-2017-01249.pdf, http://j-stroke.org/journal/view.php?doi=10.5853/jos.2017.01249, http://www.j-stroke.org/upload/pdf/jos-2017-01249.pdf
The Lancet10.1016/s0140-6736(09)60679-6200937396701171Cytochrome P450 2C19 polymorphism and clopidogrel after MISanjeev Bhattacharyya, Roby Rakhithttps://api.elsevier.com/content/article/PII:S0140673609606796?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0140673609606796?httpAccept=text/plain
The Lancet10.1016/s0140-6736(09)60680-2200937396701171-1172Cytochrome P450 2C19 polymorphism and clopidogrel after MIJianting Miao, Rui Liu, Zhuyi Lihttps://api.elsevier.com/content/article/PII:S0140673609606802?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0140673609606802?httpAccept=text/plain
The Lancet10.1016/s0140-6736(09)60681-4200937396701172Cytochrome P450 2C19 polymorphism and clopidogrel after MIRadhakrishnan Ramarajhttps://api.elsevier.com/content/article/PII:S0140673609606814?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0140673609606814?httpAccept=text/plain
The Lancet10.1016/s0140-6736(09)60682-6200937396701172-1173Cytochrome P450 2C19 polymorphism and clopidogrel after MI – Authors' replyJP Collet, JS Hulot, G Montalescothttps://api.elsevier.com/content/article/PII:S0140673609606826?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0140673609606826?httpAccept=text/plain
Clinical Pharmacology: Advances and Applications10.2147/cpaa.s27822201213Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel responseRolf Kreutz, Nystrom, Kreutz, Miao, Desta, Jeffrey Breall, Li, Chiang, Kovacs, Flockhart, Jinhttps://www.dovepress.com/getfile.php?fileID=12082
Yearbook of Cardiology10.1016/s0145-4145(09)79743-620102010278-280Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort studyB.J. Gershhttps://api.elsevier.com/content/article/PII:S0145414509797436?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0145414509797436?httpAccept=text/plain
Yonsei Medical Journal10.3349/ymj.2011.52.5.7342011525734Cytochrome P450 2C19 Polymorphism is Associated with Reduced Clopidogrel Response in Cerebrovascular DiseaseJun-Beom Lee, Kyung-A Lee, Kyung-Yul Leehttps://synapse.koreamed.org/DOIx.php?id=10.3349/ymj.2011.52.5.734, https://synapse.koreamed.org/pdf/10.3349/ymj.2011.52.5.734, https://eymj.org/DOIx.php?id=10.3349/ymj.2011.52.5.734
xPharm: The Comprehensive Pharmacology Reference10.1016/b978-008055232-3.60515-x20071-6Cytochrome P450 Monooxygenase 2C19Manuel Baader, Urs A. Meyerhttps://api.elsevier.com/content/article/PII:B978008055232360515X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:B978008055232360515X?httpAccept=text/plain